Skip to main content

5 Stock Gainers for Wednesday: Novavax, Fiverr,

Novavax, Fiverr Technology,, Horizon Therapeutics, and Emergent Biosolutions are among Wednesday's big gainers.

Stocks finished higher Wednesday as Walt Disney  (DIS) - Get Free Report posted a modest profit despite the coronavirus pandemic and Johnson & Johnson  (JNJ) - Get Free Report reached an agreement with the U.S. on a potential coronavirus vaccine. The Nasdaq finished at a record. 

Here are some of the market's biggest gainers for Wednesday:

1. Novavax | Percentage Increase Over 8%

Novavax  (NVAX) - Get Free Report surged after the biotech company said its trial vaccine to prevent covid-19 generated a promising immune response in an early-stage clinical trial.

2. Fiverr | Percentage Increase Over 17%

Fiverr (FVRR) - Get Free Report was climbing after the online marketplace beat Wall Street's second-quarter earnings and revenue estimates. Revenue grew 82% year-over-year, the company said, "with strong execution across product, marketing and operation during the global pandemic."

3. Horizon Therapeutics | Percentage Increase Over 23%

Horizon Therapeutics  (HZNP) - Get Free Report surged after the biopharmaceutical company reported better-than-expected second-quarter financial results Wednesday. Sales jumped 44% year over year to $462.8 million, the company said. | Percentage Increase Over 13%  (OSTK) - Get Free Report was higher Wednesday. The online retailer recently beat Wall Street second-quarter earnings expectations, with net revenue doubling to $783 million and the number of new customers more than tripling year over year.

5. Emergent BioSolutions | Percentage Increase Over 9%

Emergent BioSolutions  (EBS) - Get Free Report finished higher after Moody's Investors Service assigned a Ba2 corporate family rating to the life sciences company. Moody's anticipates "steady ongoing growth in Emergent's anthrax and smallpox vaccines supplied to the US Strategic National Stockpile." Coronavirus vaccine manufacturing contracts with companies like Johnson & Johnson  (JNJ) - Get Free Report and AstraZeneca PLC  (AZN) - Get Free Report, and the US government will bolster Emergent's contract development and manufacturing organization business, Moody's said.